Composite local low-rank structure in learning drug sensitivity.
暂无分享,去创建一个
Jukka Corander | Zhi Zhao | Manuela Zucknick | The Tien Mai | Leiv Ronneberg | J. Corander | T. T. Mai | M. Zucknick | Leiv Rønneberg | Zhi Zhao
[1] A. Lusis,et al. Considerations for the design of omics studies , 2017 .
[2] Tero Aittokallio,et al. Machine learning and feature selection for drug response prediction in precision oncology applications , 2018, Biophysical Reviews.
[3] A. Roslani,et al. Heterogeneity in cancer cells: variation in drug response in different primary and secondary colorectal cancer cell lines in vitro , 2017, In Vitro Cellular & Developmental Biology - Animal.
[4] Joel Greshock,et al. Molecular target class is predictive of in vitro response profile. , 2010, Cancer research.
[5] Adam A. Margolin,et al. The Cancer Cell Line Encyclopedia enables predictive modeling of anticancer drug sensitivity , 2012, Nature.
[6] Laura M. Heiser,et al. A community effort to assess and improve drug sensitivity prediction algorithms , 2014, Nature Biotechnology.
[7] Krister Wennerberg,et al. Global proteomics profiling improves drug sensitivity prediction: results from a multi-omics, pan-cancer modeling approach , 2017, Bioinform..
[8] Tero Aittokallio,et al. Drug response prediction by inferring pathway-response associations with kernelized Bayesian matrix factorization , 2016, Bioinform..
[9] Sridhar Ramaswamy,et al. Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells , 2012, Nucleic Acids Res..
[10] Nci Dream Community. A community effort to assess and improve drug sensitivity prediction algorithms , 2014 .
[11] S. Ramaswamy,et al. Systematic identification of genomic markers of drug sensitivity in cancer cells , 2012, Nature.
[12] Xiaokang Liu,et al. Integrative multi‐view regression: Bridging group‐sparse and low‐rank models , 2019, Biometrics.
[13] M. Stratton,et al. Abstract 2206: Genomics of Drug Sensitivity in Cancer (GDSC): A resource for therapeutic biomarker discovery in cancer cells. , 2013 .
[14] Zhi Zhao,et al. Structured penalized regression for drug sensitivity prediction , 2019, Journal of the Royal Statistical Society: Series C (Applied Statistics).
[15] D G Hoel,et al. Fundamental carcinogenic processes and their implications for low dose risk assessment. , 1976, Cancer research.
[16] Scott E. Martin,et al. Reproducible pharmacogenomic profiling of cancer cell line panels , 2016, Nature.